Although former KENS-TV reporter and forecaster Maggie Laughlin may have left San Antonio to start her acting and modeling ...

In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expect ...

Citi said SMid biotech sentiment has been more challenged than expected in early 2025, largely due to investor focus on ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

A new high-profile event dedicated to global TV series is being launched in Italy with “Bridgerton” star Adjoa Andoh, ...

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

It was perhaps not the welcome Irish Prime Minister Micheal Martin had hoped for on an annual US trip to mark Saint Patrick's ...

Jeff Lilly has been named director of technology for Nexstar’s Chicago owned station WGN.

WASHINGTON, D.C. U.S. Senate Democratic Whip Dick Durbin (D-IL) sent letters to five telehealth companies that have held ...